PRESS RELEASE: Lenstec Expands Softec HD Series With Approval Of HDM (MICRO) Intraocular Lens
Lenstec, Inc, a manufacturer of technologically advanced implantable lenses for correcting vision, today announced it has expanded its Softec HD product line with the Softec HDM, which was approved by the U.S. Food & Drug Administration in March. lenstec hdm final by api-250128222
Read More
Lens Replacement Surgery Could Save Thousands From Sudden Blindness
A new type of lens replacement surgery treatment could be used for a rare type of glaucoma, which can lead to a sudden attack that destroys vision in as little as 24 hours. groundbreaking lens replace… by api-250128222
Read More
Lenstec Begins FDA Trials Of Implantable Bi-Focal Quarter Diopter Lens
ST. PETERSBURG, Florida, August 18, 2015—Lenstec, Inc.—an established medical device manufacturer of technologically advanced implantable lenses for treating vision disorders—today announced the start of an FDA trial in support of gaining FDA clearance for its Segmented Bi-focal lens (SBL-3).
Read More
Lenstec Donates Over $1,800 Participating In The Making Strides For Breast Cancer Walk
ST PETERSBURG, FL – On Saturday, October 18, Lenstec employees gathered together for the Making Strides for Breast Cancer Walk in St Petersburg, Florida. Over $900 was raised in support of one of our employees, Nouanthip “Cat” Manipakone, which was matched by Lenstec 100%. All proceeds were donated to the American Cancer Society.
Read More
Refractive Accuracy: Prediction Error Distribution With Quarter Diopter IOLs
By William B. Trattler, M.D., Neel R. Desai, M.D., Carlos Buznego, M.D., and Gabriela Perez, B.S. Cataract surgery has been touted as one of the most common operations in the United States with over 3 million procedures performed per year. Perhaps more impressively, this invasive procedure is also one of the most successful. With success rates estimated at ~99%…
Read More
The Case For An Oval Optic
by Dr. Dale Pilkinton, M.D. All cataract patients have some artifact or light-scattering phenomenon after IOL implantation, regardless of implant style, size, or material. Surgeons see this in many forms, characterized as either TCS (temporal crescent syndrome), dysphotopsia, edge glare, or other monikers. In our clinic, we have seen this for over 20 years. It…
Read More
Case Report – Negative Dysphotopsia – Jeremy Kieval, MD
Convincing a referred patient to move ahead with second-eye surgery was not an easy task. Today, 20/20 is not always an acceptable outcome for premium lens patients. Even with all the advances in IOLs and surgical technologies, visual anomalies can still occur, and an IOL’s optic design may or may not be a factor.1 Among…
Read More
Blended Vision An Option For Improving Vision At All Distances In Pseudophakic Patients – Cynthia Matossian
A ‘mini-monovision’ approach with bilaterally implanted Softec HD IOLs demonstrated positive results.
Read More
Prediction Power More Accurate For IOLs With Labeled Manufacturing Tolerance
Compiled by Callan Navitsky, Associate Editor, and Steve Daily, News Editor Intraocular lenses (IOLs) available in 0.25 D increments with a labeled manufacturing tolerance significantly increased the percentage of patients achieving a refraction within ±0.25 D of the target. This improvement was statistically significant and clinically meaningful compared to unlabeled IOLs available in 0.50 D…
Read More